Author: Ashish Goyal; E. Fabian Cardozo-Ojeda; Joshua T Schiffer
Title: Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response Document date: 2020_4_14
ID: d7stppv5_14
Snippet: Finally, we combined the PK and PD models as in Fig. 3a to project the percentage of viral replication inhibited over time at different assumed intracellular EC50 values (18, 19) . With high assumed drug potency (EC50=0.8 uM), antiviral effect are sustained over the 10-day dosing interval and are maintained for a long period once drug delivery has stopped (Fig. 3e) . At higher assumed EC50 values, remdesivir potency is projected to be lower......
Document: Finally, we combined the PK and PD models as in Fig. 3a to project the percentage of viral replication inhibited over time at different assumed intracellular EC50 values (18, 19) . With high assumed drug potency (EC50=0.8 uM), antiviral effect are sustained over the 10-day dosing interval and are maintained for a long period once drug delivery has stopped (Fig. 3e) . At higher assumed EC50 values, remdesivir potency is projected to be lower.
Search related documents:
Co phrase search for related documents- antiviral effect and drug potency: 1, 2
- antiviral effect and long period: 1
- antiviral effect and time inhibit: 1
- different time inhibit and time inhibit: 1
- dose interval and PD PK model: 1
Co phrase search for related documents, hyperlinks ordered by date